News

Meyers & Flowers $43.5 Million Jury Verdict Ranked in Top 10 Medical Malpractice Verdicts in the United States for 2023

12/19/2024

FOR IMMEDIATE RELEASE Meyers & Flowers Secures Spot in Top 10 Medical Malpractice Verdicts of 2023 with $43.5 Million Jury Award CHICAGO - Meyers & Flowers is proud to announce that its $43.5 million jury verdict on behalf of former Philadelphia Eagles team captain Chris Maragos has been recognized as one of the Top 10 Medical Malpractice Verdicts in the United States for 2023 by Top Verdi...

Meyers & Flowers LLC Welcomes New Of Counsel Attorney, Betsy Holder

12/09/2024

Meyers & Flowers welcomes Betsy Holder as Of Counsel to expand legal services in Champaign, Illinois. Champaign, IL - Meyers & Flowers, a leading law firm known for its commitment to justice and excellence in representing clients across a range of complex legal matters, is thrilled to announce the addition of Betsy Holder as Of Counsel. Attorney Holder brings over a decade of personal inju...

Meyers & Flowers Ranked In 2025 Best Law Firms® For the 14th Year

11/25/2024

Chicago, IL, November 2024 - Meyers & Flowers, LLC is proud to announce its inclusion in the 2025 Edition of Best Law Firms®, a prestigious ranking by Best Lawyers® that recognizes firms for their professional excellence and consistently high ratings from both clients and peers. For the 14th consecutive year, Meyers & Flowers has achieved top-tier rankings, reflecting the firm's co...

First Lawsuits Filed Against McDonalds for E. Coli Outbreak Linked to Quarter Pounders

11/11/2024

Ron Simon & Associates and Meyers & Flowers have filed the first lawsuits in response to a recent E. coli outbreak linked to McDonald's restaurants. The lawsuits were filed on behalf of two residents—one from Colorado and one from Nebraska—who allege they became severely ill after consuming McDonald's Quarter Pounders in their respective locations. This outbreak has raised pub...

Dacthal Pesticide Exposure: Risks and Legal Recourse

11/04/2024

The Environmental Protection Agency (EPA) has recently taken significant steps to protect public health by issuing an emergency directive suspending the use of Dacthal, a widely used pesticide linked to serious health risks. This suspension comes amid growing concerns, especially for pregnant individuals and children, who may face long-term health effects from exposure. Meyers & Flowers is act...

The Rising Concerns Around Depo-Provera: What You Need to Know About Meningioma Lawsuits

10/25/2024

Depo-Provera, a popular contraceptive injection, has been at the center of recent legal action due to its potential link to serious health issues, particularly meningiomas—tumors that form in the membranes surrounding the brain and spinal cord. Pfizer, the pharmaceutical giant responsible for Depo-Provera, is facing lawsuits representing women who have developed these brain and spinal tumor...

Fisher-Price Recalls Over 2 Million ‘Snuga Swings’ Following Reports of Infant Deaths

10/15/2024

Fisher-Price has issued a recall of more than 2 million "Snuga Swings" due to a suffocation risk, with five infant deaths linked to the product between 2012 and 2022. The swings were reportedly used improperly for sleep, and in many cases, the infants were unrestrained, with added bedding materials contributing to the fatal outcomes. According to the Consumer Product Safety Commission (CPSC), the ...

Members of Congress Call for Ban on Herbicide Linked to Parkinson’s and Cancer

10/15/2024

A group of 47 members of Congress, led by Rep. Greg Casar, has called on the Environmental Protection Agency (EPA) to ban the herbicide paraquat, which has been linked to Parkinson's disease and cancer. This urgent plea follows mounting evidence showing the harmful effects of paraquat on farmers and communities exposed to the chemical. A growing body of scientific research has found paraquat to be...

Acadia Healthcare is Holding People Against Their Will to Maximize Insurance Payouts

10/04/2024

Acadia Healthcare, one of the largest psychiatric hospital chains in the U.S., has been mired in controversy for years due to allegations of unethical practices and fraudulent detainment of patients. The company has faced numerous investigations and lawsuits, including a recent $19.85 million settlement with the U.S. Department of Justice over claims that it billed for medically unnecessary servic...

Oxbryta® Recall: Pfizer Pulls Sickle Cell Medication Due to Severe Side Effects

09/27/2024

Pfizer has issued a global recall of Oxbryta, a drug approved for the treatment of sickle cell disease (SCD). Oxbryta, which aimed to improve oxygen transport in red blood cells, offered hope to many individuals suffering from this debilitating condition. However, recent findings have revealed that the drug may pose serious life-threatening risks that outweigh its potential benefits, leading to th...

1 2 ... 22 23 Next

Categories